Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Snappy Acquires Covver, Redefining Global Gifting With AI-Powered Personalization and Swag Expertise
-
X4 Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize Mavorixafor in Europe, Australia, and New Zealand
-
Optimi Health Reports First Patients Dosed in Landmark Natural Psilocybin Study in New Zealand
-
Legacy Gold Announces Appointment of Michael Michaud to Board of Directors and Grant of Stock Options
-
NowVertical CEO Takes Equity Bonus in Lieu of Cash, Underscoring Shareholder Alignment
-
Winter Drill Program Resumes at the 3Ts Project, BC
-
Glow Lifetech Announces Expansion into New Brunswick Market with MOD(TM) Drops, Marking Atlantic Canada Debut
-
Fuerte Metals Geophysical Survey Confirms Two Significant Porphyry Cu-Au Targets at its Placeton Project, Chile
-
Clifton Blake Mortgage Fund Rewards Investors with 3.3x Bonus Distribution After Exceptional 2024
-
Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors
-
Amalgamated Financial Corp. Announces Fourth Quarter and Full Year 2024 Earnings Conference Call
-
Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2024 Update
-
Rio2 Provides Fenix Gold Mine Construction Update
-
Traxys and HNK Alpha Execute First Nickel Sulphate Futures Block Trade on Abaxx Commodity Futures Exchange and Clearinghouse
-
Western Resources Corp. Provides Bi-weekly MCTO Status Update
-
RBC iShares Expands Access to BlackRock’s Bitcoin ETP Platform
-
Mandalay Resources Delivers Strong Q4 Gold and Antimony Performance, Achieves Top End of 2024 Production Guidance Leading to $76 Million Cash Balance
-
Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones
-
Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare Conference
-
Cytokinetics Announces 2025 Corporate Milestones and Vision 2030
-
Endo Launches New Peyronie's Disease Campaign: I Got Somebody
-
Palladium Equity-Backed Superior Environmental Solutions Acquires American Remediation & Environmental, Inc., Further Expanding Operations into the Southeast
-
Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook
-
Corvus Pharmaceuticals Announces Data from Cohort 2 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
-
Verastem Oncology Announces Debt Refinancing with Oberland Capital and Strategic Commercialization Partnership with IQVIA to Support Potential Launch in Recurrent KRAS Mutant Low-Grade Serous Ovarian
-
URBN Reports Record Holiday Sales
-
MakeMyTrip Limited to report Fiscal 2025 Third Quarter Financial & Operating Results on January 23, 2025
-
V2X Names L. Roger Mason to Chief Growth Officer
-
Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025
-
PPM America Hires Seasoned Emerging Market Debt Team
-
GTCR Announces Strategic Investment in Winged Keel Group
-
HSBC Continental Europe: Notice of the General Meeting of Holders (ISIN Code : FR0000585333)
-
Aerin Announces New Funding to Further Fuel Growth
-
HABRI and Lap of Love Partner to Promote the Power of the Human-Animal Bond During End-of-Life Care for Pets
-
Redwire Successfully Delivers Fourth Pair of Roll-Out Solar Array Wings for ISS Power
-
TomaGold appoints Jean Lafleur, P. Geo., as Vice President, Exploration
-
Volato to Take Delivery of Second Gulfstream G280 in January 2025, Leveraging Strong Market Demand for Premium Jets
-
22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes
-
Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance
-
Arbutus Provides 2025 Corporate and Financial Update
-
Lower Colorado River Authority Widens Wireless Communications Capabilities with Additional Spectrum Licenses from Anterix
-
New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients
-
Natural Grocers® Commemorates Martin Luther King Jr. Day 2025 with Annual Fundraiser Supporting Jack and Jill of America Foundation
-
East Tennessee Company Scores the Highest Global Food Safety Rating
-
MNP Consumer Debt Index Plunges to 79 Points, the Second-Lowest Level Ever Recorded (-10pts)
-
Alliance Witan PLC - Net Asset Value
-
Form 8.3 - [ALLIANCE PHARMA PLC - Opening Disclosure - 10 01 2025] - (CGAML)
-
Sapiens Now Available in the Microsoft Azure Marketplace
-
Defense Metals Announces Share-Based Interest Payment
-
Form 8.3 - [ALLIANCE PHARMA PLC - 10 01 2025] - (CGWL)
